Self-Care Management in Chronic Disease

July 8, 2024 updated by: Ayşegül Akca, Ankara Yildirim Beyazıt University

The Effect of Health Education on Chronic Disease Management in the Elderly

Self-management of chronic diseases includes treatment and adoption of healthy behaviors. The research was planned to determine the effect of health education on disease management in the elderly with chronic diseases. The research will be conducted in a parallel group, randomized controlled manner. Older adults will receive 6 weeks of health education. After the training, the scales will be re-administered face to face or online.

Study Overview

Status

Withdrawn

Intervention / Treatment

Study Type

Interventional

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Çubuk/Turkey
      • Ankara, Çubuk/Turkey, Turkey, 06760
        • Ankara Yıldırım Beyazıt University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Older Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Being in the 65-75 age group,
  • Having a chronic disease

Exclusion Criteria:

  • Having vision and hearing problems
  • Being 76 or older
  • Having a neuro-psychiatric disease

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
No Intervention: Control
No intervention has been made.
Experimental: Education
6 weeks of health education will be provided to older adults. Once the intervention is completed, the scales will be re-administered face-to-face or online.
Health education prepared for chronic disease self-management aims to improve the health behaviors of older adults.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Chronic Disease Self-Management Scale
Time Frame: baseline
The scale, developed to evaluate self-management in chronic diseases, consists of 23 items and four subscales: Self-Stigma, Coping with Stigma, Health Care Effectiveness and Treatment Compliance. Expressions on the scale are rated between 1-5; It can be converted into a 100-point system (1=0, 2=25, 3=50 and 4=75 and 5=100) to facilitate interpretation and comparison in evaluation. A high score in the Self-Stigma subscale indicates high self-stigma, a high score in the Coping with Stigma subscale indicates a high ability to cope with stigma, a high score in Health Care Effectiveness indicates high health care effectiveness, and a high score in Treatment Compliance indicates good compliance. It was determined that the 21-item scale, adapted to Turkish in 2021, showed a four-factor structure and Cronbach alpha coefficients ranged between 0.789 and 0.876.
baseline
Chronic Disease Self-Management Scale
Time Frame: within first week
The scale, developed to evaluate self-management in chronic diseases, consists of 23 items and four subscales: Self-Stigma, Coping with Stigma, Health Care Effectiveness and Treatment Compliance. Expressions on the scale are rated between 1-5; It can be converted into a 100-point system (1=0, 2=25, 3=50 and 4=75 and 5=100) to facilitate interpretation and comparison in evaluation. A high score in the Self-Stigma subscale indicates high self-stigma, a high score in the Coping with Stigma subscale indicates a high ability to cope with stigma, a high score in Health Care Effectiveness indicates high health care effectiveness, and a high score in Treatment Compliance indicates good compliance. It was determined that the 21-item scale, adapted to Turkish in 2021, showed a four-factor structure and Cronbach alpha coefficients ranged between 0.789 and 0.876.
within first week

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

April 22, 2024

Primary Completion (Estimated)

April 22, 2025

Study Completion (Estimated)

June 30, 2025

Study Registration Dates

First Submitted

March 29, 2024

First Submitted That Met QC Criteria

March 29, 2024

First Posted (Actual)

April 4, 2024

Study Record Updates

Last Update Posted (Actual)

July 10, 2024

Last Update Submitted That Met QC Criteria

July 8, 2024

Last Verified

March 1, 2024

More Information

Terms related to this study

Other Study ID Numbers

  • 2023-031

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Disease Self Management

Clinical Trials on Health education

Subscribe